Company: KCHVR
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076631
Chunk: 82

Company: Kochav Defense Acquisition Corp.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 82
---
 succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial
Reporting

Not applicable.

21

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

To the knowledge of our Management Team, there
is no material litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or
against any of our property.

Item 1A. Risk Factors.

As a smaller reporting company under Rule 12b-2
of the Exchange Act, we are not required to include risk factors in this Report. For additional
risks relating to our operations, other than as set forth below see the section titled “Risk Factors” contained in our IPO
Registration Statement. Any of these factors could result in a significant or material adverse effect on our results of operations or
financial condition. Additional risks could arise that may also affect our ability to consummate an initial Business Combination. We may
disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

We may seek to extend the Combination Period,
which could reduce the amount held in our Trust Account and have adverse effects on our Company. 

If we are unable to consummate our initial Business
Combination on or before May 29, 2027 (if we extend the Combination Period pursuant to our Amended and Restatement Articles), we may seek
shareholder approval to further extend the Combination Period by amending our Amended and Restated Articles. In such event, our Public
Shareholders will be provided the opportunity to have all or a portion of their Public Shares redeemed. Any redemptions will reduce the
amount held in our Trust Account, the effect of which may adversely affect our ability to consummate our initial Business Combination
and may also impair our ability to maintain our Nasdaq listing.

We anticipate that our securities will be
suspended from trading on Nasdaq and delisted if we do not consummate our initial Business Combination by May 27, 2028. Any trading suspension
or delisting could have a material adverse effect on the trading of our securities and may adversely affect our ability to consummate
an initial Business Combination.

Our IPO Registration Statement was declared effective
by the SEC on May 27, 2025 and our securities are currently listed on the Global Market tier of Nasdaq. Pursuant to our Amended and Restated
Articles, we have until May 29, 2027 to consummate our initial